Syngene International commissions dedicated R&D center for Amgen

Thursday, September 8, 2016

Syngene International, one of Asia’s largest R&D-focused CROs, has announced the establishment in Bangalore, India, of an integrated, multi-disciplinary drug discovery and development center for Amgen. This center, named Syngene Amgen R&D Center (SARC), will be Syngene’s fourth such exclusive R&D center. Syngene already operates dedicated R&D centers for Bristol-Myers Squibb, Abbott Nutrition and Baxter.

[Read More]